ATP13A3 anticorps (AA 101-129)

N° du produit ABIN2589323

Détail du produit anti-ATP13A3 anticorps

Antigène: ATP13A3 (ATPase Type 13A3 (ATP13A3))

Épitope: AA 101-129

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ATP13A3 est non-conjugé

Application: Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (IHC), ELISA

Specificité: This ATP13A3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 101-129 amino acids from the N-terminal region of human ATP13A3.

Purification: Affinity purified

Isotype: IgG

Information d'application

Indications d'application: Approved: ELISA (1:1000), Flo (1:10 - 1:50), IHC (1:50 - 1:100), WB (1:100 - 1:500)

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: PBS,  pH 7.2, 0.09 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Aliquot to avoid repeated freezing and thawing.

Stock: 4 °C,-20 °C

Stockage commentaire: May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for 1 year.

Détails sur ATP13A3

Antigène: ATP13A3 (ATPase Type 13A3 (ATP13A3))

Autre désignation: ATP13A3 (ATP13A3 Produits)

Synonymes: anticorps AFURS1, anticorps AU022875, anticorps Gm1745, anticorps Gm541, anticorps Gm542, anticorps ATPase 13A3, anticorps probable cation-transporting ATPase 13A3, anticorps ATPase type 13A3, anticorps ATP13A3, anticorps LOC577790, anticorps LOC100163879, anticorps LOC100202365, anticorps atp13a3, anticorps LOC100561002, anticorps Atp13a3

Sujet: Name/Gene ID: ATP13A3
Subfamily: ATPase - P type, type V
Family: Transporter

Synonyms: ATP13A3, AFURS1, ATPase type 13A3

ID gène: 79572

Pathways: SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2